Review article: Current indications and selection criteria for early liver transplantation in severe

Carolina Ramirez-Cadiz1, Hanna Blaney2, Natalia Kubanek3

  • 1Department of Anesthesia and Perioperative Medicine, Schulich School of Medicine, Western University & London Health Sciences Centre, London, Ontario, Canada.

Insights

Early liver transplantation for severe alcohol-associated hepatitis (AH) shows survival benefits, but patient selection criteria need refinement. An integrated approach is crucial for managing alcohol use disorder risks.

Area of Science:

  • Hepatology
  • Transplantation Surgery
  • Addiction Medicine

Background:

  • Alcohol-associated hepatitis (AH) is a severe, high-mortality liver disease.
  • Early liver transplantation is an emerging option for severe AH.
  • Referral and selection criteria for early liver transplantation are debated.

Purpose of the Study:

  • To review the natural history of severe AH.
  • To outline diagnostic criteria for AH.
  • To discuss indications for early liver transplantation in AH.

Main Methods:

  • PubMed database search conducted through August 2023.
  • Key search terms included 'alcoholic hepatitis,' 'abstinence,' and 'liver transplantation.'
  • Narrative review methodology employed.

Main Results:

  • Historically, a six-month abstinence period was required for liver transplantation in alcohol-associated liver disease (ALD).
  • Selected patients receiving early transplants demonstrate significantly higher survival rates (77%) compared to non-transplanted patients (23%).
  • Early transplantation is controversial due to the risk of alcohol relapse without prior alcohol use disorder treatment.

Conclusions:

  • Early liver transplantation offers survival advantages for severe AH.
  • Many candidates for early transplantation may not have undergone alcohol use disorder treatment.
  • An integrated evaluation approach is necessary for candidacy in early liver transplantation.
Abstract

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
274
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
30